Cargando…

No Immunogenicity of IPS Cells in Syngeneic Host Studied by In Vivo Injection and 3D Scaffold Experiments

Induced Pluripotent Stem Cells (IPSCs) open the great possibility to employ patient's own tissue to the previously incurable diseases. However these cells can be used in cell therapy only if they are not rejected when transplanted back into the syngeneic host. We found that the injection of iPS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thanasegaran, Suganya, Cheng, Zhao, Ito, Sachiko, Nishio, Naomi, Isobe, Ken-ichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652117/ https://www.ncbi.nlm.nih.gov/pubmed/23691499 http://dx.doi.org/10.1155/2013/378207

Ejemplares similares

Establishment of Self-Renewable GM-CSF-Dependent Immature Macrophages In Vitro from Murine Bone Marrow
por: Ito, Sachiko, et al.
Publicado: (2013)

GADD34 inhibits activation-induced apoptosis of macrophages through enhancement of autophagy
por: Ito, Sachiko, et al.
Publicado: (2015)

Negative Regulation of GADD34 on Myofibroblasts during Cutaneous Wound Healing
por: Liu, Lintao, et al.
Publicado: (2014)

Effects of growth arrest and DNA damage-inducible protein 34 (GADD34) on inflammation-induced colon cancer in mice
por: Tanaka, Yuriko, et al.
Publicado: (2015)

Enhancement of the Acrolein-Induced Production of Reactive Oxygen Species and Lung Injury by GADD34
por: Sun, Yang, et al.
Publicado: (2015)

GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease, hepatic carcinoma and insulin resistance
por: Nishio, Naomi, et al.
Publicado: (2015)

A Cross-Reacting Embryonic Antigen in the Membrane of Rat Sarcoma Cells which is Immunogenic in the Syngeneic Host
por: Thomson, D. M. P., et al.
Publicado: (1973)

Non-immunogenicity of enucleated rat hepatoma cells in syngeneic animals.
por: Gerlier, D., et al.
Publicado: (1981)

Immunological aspects of age-related diseases
por: Isobe, Ken-ichi, et al.
Publicado: (2017)

Comparative Angiogenic Activities of Induced Pluripotent Stem Cells Derived from Young and Old Mice
por: Suzuki, Hirohiko, et al.
Publicado: (2012)

Monocytosis associated with the growth of transplanted syngeneic rat sarcomata differing in immunogenicity.
por: Eccles, S. A., et al.
Publicado: (1976)

Macrothrombocytopenia of Takenouchi-Kosaki syndrome is ameliorated by CDC42 specific- and lipidation inhibitors in MEG-01 cells
por: Daimon, Etsuko, et al.
Publicado: (2021)

Vancomycin-sensitive bacteria trigger development of colitis-associated colon cancer by attracting neutrophils
por: Tanaka, Yuriko, et al.
Publicado: (2016)

iPS cell sheets created by a novel magnetite tissue engineering method for reparative angiogenesis
por: Kito, Tetsutaro, et al.
Publicado: (2013)

Growth of Syngeneic Tumours in Unimmunized Newborn and Adult Hosts
por: Forni, G., et al.
Publicado: (1973)

Selective, high-contrast detection of syngeneic glioblastoma in vivo
por: Banati, Richard B., et al.
Publicado: (2020)

Promotion of fibrosarcoma cell growth by products of syngeneic host macrophages.
por: Currie, G. A.
Publicado: (1981)

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice
Publicado: (1980)

The impact of tumor immunogenicity on cancer pain phenotype using syngeneic oral cancer mouse models
por: Horan, Nicole L., et al.
Publicado: (2022)

PRODUCTION OF RUNT DISEASE IN TOLERANT MICE BY THE INJECTION OF SYNGENEIC LYMPHOID CELLS
por: Hilgard, Henry R., et al.
Publicado: (1965)

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
por: Timmons, Joshua J., et al.
Publicado: (2016)

Author Correction: Selective, high-contrast detection of syngeneic glioblastoma in vivo
por: Banati, Richard B., et al.
Publicado: (2020)

Radiation-induced myeloid leukaemia in CBA/H mice: a non-immunogenic malignant disease in syngeneic mice.
por: Meldrum, R. A., et al.
Publicado: (1982)

Comparison of Muscle Regeneration after BMSC-Conditioned Medium, Syngeneic, or Allogeneic BMSC Injection
por: Świerczek-Lasek, Barbara, et al.
Publicado: (2022)

In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment
Publicado: (1990)

Syngeneic antitumour antibodies in rats: clearance of cell-bound antibody in vivo and in vitro.
por: Dean, C. J., et al.
Publicado: (1982)

Inhibition of Chondrosarcoma Growth by mTOR Inhibitor in an In Vivo Syngeneic Rat Model
por: Perez, Jennifer, et al.
Publicado: (2012)

Effect of solubilized membrane antigens and tumour bearer serum on tumour growth in syngeneic hosts.
por: Forni, G., et al.
Publicado: (1974)

Requirements for the induction and adoptive transfer of cyclosporine- induced syngeneic graft-versus-host disease
Publicado: (1989)

A mouse model of prostate cancer bone metastasis in a syngeneic immunocompetent host
por: Simons, Brian W., et al.
Publicado: (2019)

Effect of carrageenan on the non-specific resistance of mice to injected syngeneic tumour cells, alone or in mixtures.
por: Wu, R. L., et al.
Publicado: (1979)

THE DISTRIBUTION OF LARGE DIVIDING LYMPH NODE CELLS IN SYNGENEIC RECIPIENT RATS AFTER INTRAVENOUS INJECTION
por: Griscelli, Claude, et al.
Publicado: (1969)

Tumourigenicity and Immunogenicity of Induced Neural Stem Cell Grafts Versus Induced Pluripotent Stem Cell Grafts in Syngeneic Mouse Brain
por: Gao, Mou, et al.
Publicado: (2016)

PROLIFERATION OF DONOR MARROW AND THYMUS CELLS IN THE MYELOID AND LYMPHOID ORGANS OF IRRADIATED SYNGENEIC HOST MICE
por: Takada, Akikazu, et al.
Publicado: (1973)

Generation of a Syngeneic Heterozygous ACVRL1((wt/mut)) Knockout iPS Cell Line for the In Vitro Study of HHT2-Associated Angiogenesis
por: Xiang-Tischhauser, Li, et al.
Publicado: (2023)

Lack of correlation between in vivo rejection of syngeneic fibrosarcomas and in vitro non-specific macrophage cytotoxicity.
por: Evans, R., et al.
Publicado: (1978)

Mechanisms of syngeneic tumor rejection. Susceptibility of host- selected progressor variants to various immunological effector cells
Publicado: (1982)

Application of Injectable, Crosslinked, Fibrin-Containing Hyaluronic Acid Scaffolds for In Vivo Remodeling
por: Hinsenkamp, Adél, et al.
Publicado: (2022)

Establishment of a syngeneic orthotopic model of prostate cancer in immunocompetent rats
por: Suzuki, Shugo, et al.
Publicado: (2014)

Syngeneic antiidiotypic immune responses to a B cell lymphoma. Comparison between heavy chain hypervariable region peptides and intact Ig as immunogens
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_vdr213svuc3171k5a50vk1vnk9